Insider Buying: Creo Medical Group (LON:CREO) Insider Buys £883.96 in Stock

Creo Medical Group PLC (LON:CREO) insider Craig Jonathan Gulliford purchased 8,036 shares of the stock in a transaction that occurred on Tuesday, January 13th. The shares were bought at an average cost of GBX 11 per share, for a total transaction of £883.96.

Creo Medical Group Stock Up 2.2%

Creo Medical Group stock opened at GBX 11.50 on Friday. The stock has a 50 day moving average of GBX 10.39 and a two-hundred day moving average of GBX 11.73. Creo Medical Group PLC has a twelve month low of GBX 9.22 and a twelve month high of GBX 22.50. The stock has a market capitalization of £47.43 million, a price-to-earnings ratio of -11.50 and a beta of 0.86. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.